Mohamed-Eslam F Mohamed

21PUBLICATIONS
49CO-AUTHORS
Toxicology (incl. clinical toxicology)Haematological tumoursPharmacogenomicsGene and molecular therapyMedical and biological physics not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 19, 2026
Efficacy, Safety, and Pharmacokinetics of Upadacitinib Among Patients in East Asia With Moderately to Severely Active Ulcerative Colitis: A Post Hoc Subanalysis of Randomized Phase 3 Studies.

|Jul 07, 2026
Epcoritamab Step-Up Dosing Regimen Selection and Optimization Using Repeated Time-to-Event Modeling for Cytokine Release Syndrome Risk Mitigation.

|May 15, 2026
Model-Informed Dosing Strategies for Epcoritamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma.

|Nov 14, 2025
Generating Control Groups for Organ Impairment Studies: A Case-Study Comparing Statistical and Population Pharmacokinetic-Based Matching Approaches.

Jessica Barry, Sumit Bhatnagar, Wei Liu

|Aug 05, 2025
Model-Informed Paradigm in Drug Development-An End-To-End Case Study From Upadacitinib Development.

Sumit Bhatnagar, Sven Stodtmann, Yuli Qian

|Dec 17, 2024
Endogenous plasma riboflavin is not a viable BCRP biomarker in human.

John P Savaryn, Ryota Kikuchi, Yuli Qian

Pageof 4

Frequent Collaborators

7 joint publications

Wei Liu

6 joint publications

Yuli Qian

5 joint publications

Sumit Bhatnagar

4 joint publications

Sven Stodtmann